Introducing the society for immunotherapy of cancer’s new journal: journal for immunoTherapy of cancer
1 Ludwig Center for Cancer Research, Lausanne, Switzerland
2 Society for Immunotherapy of Cancer (SITC), Milwaukee, WI, USA
3 Sidra Medical and Research Center, Doha, Qatar
Journal for ImmunoTherapy of Cancer 2013, 1:1 doi:10.1186/2051-1426-1-1Published: 29 May 2013
First paragraph (this article has no abstract)
The field of cancer immunology and immunotherapy is experiencing a tremendous increase in excitement and momentum, catalyzed by the latest approvals of immunotherapy-based treatments in multiple cancer types. Contributing to the excitement, more cancer vaccine candidates, immunomodulatory monoclonal antibodies and cellular therapies are showing great promise and major pharma companies are driving their development into future novel cancer treatments.